All articles by Miranda Mclaren

Debunking five misconceptions about community-based research sites in clinical trials

Clinical trials often face significant challenges in recruiting and retaining diverse participants, which can lead to skewed data and less…
The science of viscous drug product filling: Pumps, pressure, and process optimization

This article explores the operational mechanics and methods best suited to certain viscosity ranges, including considerations for pump and tubing…
Could preventative care save the future of the NHS?

“The National Health Service in England is in serious trouble” according to a landmark investigation by the Rt Hon Professor…
Navigating the confluence of AI and community-based trials: Is this the solution to improved diversity in clinical research?

Early adoption of artificial intelligence (AI) is already changing the game in clinical trials, with AI enabling some companies to…
EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta

EmVenio Research recently announced it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas.…

EmVenio Research celebrates Prime Healthcare partnership with ribbon-cutting

Clinical research organization EmVenio Research, a PCM Trials company, recently celebrated its partnership with Prime Healthcare in a grand opening event…
Managing temperature-sensitive injectable drugs in fill finish operations

Temperature sensitivity is a primary concern for many parenteral drug products. Certain medications require cold storage, freezing, or lyophilization to…
Demystifying the role of the QP in the clinical trial supply chain

“We don’t want to reject a batch; we understand the role we play in these supply chains and the development…
The crucial role of mobile visits in a DCT for interstitial lung disease

Interstitial lung diseases (ILDs) are a range of conditions characterized by inflammation (fibrosis) of the alveolar wall. One of the…
Five common misconceptions about mobile visits in clinical trials

With decentralization now widely recognized as an established tool in the clinical trial toolbox, an increasing number of sponsors and…